Good morning, Boston. Here are the five most important things you need to know to start your workday.
Rubius eyes sale; Surface cuts staff
Rowan Walrath reports that Rubius Therapeutics Inc. could be in its final days, as the Flagship Pioneering spinout lays off 82% of its workforce and looks at a sale or merger. Meanwhile, Surface Oncology Inc. has laid off one-fifth of its staff as it stops work on a mid-stage drug.
Boston Chops reopening downtown location
After a nearly three-year pandemic…
